Key result
Cerebral embolic protection devices reduce cerebral infarct volume during transcatheter aortic valve replacement, but their impact on clinically evident ischemic strokes remains unclear.
Why the study?
Do cerebral embolic protection devices reduce the risk of peri-procedural ischemic stroke in patients undergoing transcatheter aortic valve replacement?
Population
Patients with severe aortic stenosis who have prohibitive or high surgical risk undergoing transcatheter…
Design
Systematic_review
Authors
Loading...
Does not support routine cerebral embolic protection in TAVR; leaves open whether clinical stroke reduction justifies adoption.
Do cerebral embolic protection devices reduce the risk of peri-procedural ischemic stroke in patients undergoing transcatheter aortic valve replacement?
This systematic review evaluates the current evidence for using cerebral embolic protection devices to minimize peri-procedural stroke risk during TAVR.
Demir et al. (2018) conducted a review in Severe aortic stenosis undergoing Transcatheter Aortic Valve Replacement (TAVR). Cerebral Embolic Protection Devices (CEPD) vs. Unprotected TAVR was evaluated. Cerebral embolic protection devices reduce cerebral infarct volume during transcatheter aortic valve replacement, but their impact on clinically evident ischemic strokes remains unclear.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: